Status:
NOT_YET_RECRUITING
Endoscopic Treatment of Zenker's Diverticulum (ZENKTUN)
Lead Sponsor:
Société Française d'Endoscopie Digestive
Conditions:
Zenker Diverticulum
Eligibility:
All Genders
18-90 years
Brief Summary
Prospective comparative observational study in numerous reference centers in France, comparing Tunnelization (Z-POEM) versus Non-Tunnelization Techniques according to the usual practices. This is a pr...
Eligibility Criteria
Inclusion
- Patients with symptomatic Zenker's diverticulum (Augsburg score ≥5 )
- Diagnostic evaluation including esophagogastroduodenoscopy (EGD) and a barium swallow (TOGD) with measurement of the diverticulum's height.
- Patient aged 18 years or older
- Patient with ASA 1, ASA 2, ASA 3 status
- No participation in another concurrent clinical study
Exclusion
- Patient under 18 years old
- Patient with ASA 4 or ASA 5 status
- Pregnant woman
- Patient with coagulation disorders preventing the performance a polypectomy: PT \< 50%, Platelets \< 50,000/mm³, ongoing effective anticoagulation, or current clopidogrel use.
- Patient who has already undergone initial endoscopic or surgical treatment for Zenker's diverticulum
Key Trial Info
Start Date :
October 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2028
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06594718
Start Date
October 31 2024
End Date
October 31 2028
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.